199 related articles for article (PubMed ID: 27247934)
21. Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study.
Świtlik WZ; Karbownik MS; Suwalski M; Kozak J; Szemraj J
Genet Test Mol Biomarkers; 2019 May; 23(5):353-358. PubMed ID: 30950648
[No Abstract] [Full Text] [Related]
22. Upregulated Expression of Serum Exosomal microRNAs as Diagnostic Biomarkers of Lung Adenocarcinoma.
Feng M; Zhao J; Wang L; Liu J
Ann Clin Lab Sci; 2018 Nov; 48(6):712-718. PubMed ID: 30610040
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y;
World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.
Solomides CC; Evans BJ; Navenot JM; Vadigepalli R; Peiper SC; Wang ZX
Acta Cytol; 2012; 56(6):645-54. PubMed ID: 23207443
[TBL] [Abstract][Full Text] [Related]
25. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
Cho WC; Chow AS; Au JS
Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of upregulation of mir-196a-5p in gastric cancer and enriched KEGG pathway analysis of target genes.
Li HL; Xie SP; Yang YL; Cheng YX; Zhang Y; Wang J; Wang Y; Liu DL; Chen ZF; Zhou YN; Wu HY
Asian Pac J Cancer Prev; 2015; 16(5):1781-7. PubMed ID: 25773825
[TBL] [Abstract][Full Text] [Related]
27. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
[TBL] [Abstract][Full Text] [Related]
28. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers.
Yu L; Todd NW; Xing L; Xie Y; Zhang H; Liu Z; Fang H; Zhang J; Katz RL; Jiang F
Int J Cancer; 2010 Dec; 127(12):2870-8. PubMed ID: 21351266
[TBL] [Abstract][Full Text] [Related]
29. Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancer.
Yang C; Sun C; Liang X; Xie S; Huang J; Li D
Cancer Gene Ther; 2016 Apr; 23(4):90-7. PubMed ID: 26964645
[TBL] [Abstract][Full Text] [Related]
30. Circulating microRNA-339-5p and -21 in plasma as an early detection predictors of lung adenocarcinoma.
Sun Y; Mei H; Xu C; Tang H; Wei W
Pathol Res Pract; 2018 Jan; 214(1):119-125. PubMed ID: 29103767
[TBL] [Abstract][Full Text] [Related]
31. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
Song C; Chen H; Wang T; Zhang W; Ru G; Lang J
Prostate; 2015 Apr; 75(5):500-16. PubMed ID: 25597612
[TBL] [Abstract][Full Text] [Related]
32. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma.
Yang M; Liu R; Sheng J; Liao J; Wang Y; Pan E; Guo W; Pu Y; Yin L
Oncol Rep; 2013 Jan; 29(1):169-76. PubMed ID: 23124769
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
[TBL] [Abstract][Full Text] [Related]
34. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.
Duncavage E; Goodgame B; Sezhiyan A; Govindan R; Pfeifer J
J Thorac Oncol; 2010 Nov; 5(11):1755-63. PubMed ID: 20975375
[TBL] [Abstract][Full Text] [Related]
35. miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.
Zhang YK; Zhu WY; He JY; Chen DD; Huang YY; Le HB; Liu XG
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1641-50. PubMed ID: 22618509
[TBL] [Abstract][Full Text] [Related]
36. Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data.
Gan TQ; Xie ZC; Tang RX; Zhang TT; Li DY; Li ZY; Chen G
Tumour Biol; 2017 Mar; 39(3):1010428317691683. PubMed ID: 28347234
[TBL] [Abstract][Full Text] [Related]
37. Characterization of microRNA transcriptome in lung cancer by next-generation deep sequencing.
Ma J; Mannoor K; Gao L; Tan A; Guarnera MA; Zhan M; Shetty A; Stass SA; Xing L; Jiang F
Mol Oncol; 2014 Oct; 8(7):1208-19. PubMed ID: 24785186
[TBL] [Abstract][Full Text] [Related]
38. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
40. Underexpression of miR-486-5p but not Overexpression of miR-155 is Associated with Lung Cancer Stages.
Mohamed MA; Mohamed EI; El-Kaream SAA; Badawi MI; Darwish SH
Microrna; 2018; 7(2):120-127. PubMed ID: 29437031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
